Corvus Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $3.8M | $98.5M | $4.1M |
| FY2016 | $7.3M | $140.2M | $5.1M |
| FY2017 | $9.9M | $94.8M | $45.1M |
| FY2018 | $7.9M | $118.2M | $39.2M |
| FY2019 | $12.5M | $83.6M | $5.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $3.8M | $98.5M | $4.1M |
| FY2016 | $7.3M | $140.2M | $5.1M |
| FY2017 | $9.9M | $94.8M | $45.1M |
| FY2018 | $7.9M | $118.2M | $39.2M |
| FY2019 | $12.5M | $83.6M | $5.2M |